class = “cf”>
While the latest research during the pandemic has shown that the technique used in Covid vaccines can be applied to other viruses, companies have pressed the button to produce more potent vaccines.
COVID-19 AND INFLUENZA VACCINE TOGETHER
The pharmaceutical company Novavax, which has invested heavily in the development of Covid 19 vaccines, has announced that it has started testing the combined Covid-19 and influenza vaccine. “The combination of these two vaccines can offer greater efficiency to the healthcare system and provide a high level of protection against COVID-19 and influenza in a single stroke,” said Dr. Gregory Glenn, head of research and development at Novavax. noted.
FIRST TESTS IN AUSTRALIA
The first trials of the co-vaccine will take place in Australia. Researchers will administer a booster combination of the COVID-19 vaccine and the company’s flu to 640 people aged 50 to 70 who have been infected with the coronavirus or have received an approved COVID-19 vaccine for at least eight weeks prior the study.
PROVIDES BOTH INFLUENZA AND CORONA PROTECTION
class = “cf”>
Novavax announced in May that it expects the combined seasonal flu and COVID-19 vaccines to be essential in tackling emerging viral variants. In studies, the influenza vaccine from the company “NanoFlu / NVX-CoV2373” elicited strong responses against influenza A and influenza B, and also provided protection against the coronavirus.
Trial results for the combination vaccine are expected in the first half of 2022, while the company is also awaiting full FDA approval for the COVID-19 vaccine.
This guide guides gastronomy enthusiasts